pSivida Corp. (NASDAQ:PSDV) shares traded down 2% on Friday . The company traded as low as $3.33 and last traded at $3.43, with a volume of 90,543 shares trading hands. The stock had previously closed at $3.50.

Separately, FBR & Co restated a “buy” rating and set a $7.00 target price (up previously from $6.00) on shares of pSivida Corp. in a research note on Thursday, May 12th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. pSivida Corp. has an average rating of “Hold” and a consensus price target of $7.00.

The company’s market cap is $117.21 million. The stock’s 50 day moving average price is $3.23 and its 200 day moving average price is $3.15.

pSivida Corp. (NASDAQ:PSDV) last announced its earnings results on Thursday, May 5th. The company reported ($0.15) EPS for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.05. Analysts predict that pSivida Corp. will post ($0.62) earnings per share for the current year.

pSivida Corp. is a biotechnology company, which is engaged in the development of sustained-release drug-delivery products for treating eye diseases. The Company offers products for treatment of back-of-the-eye diseases. The Company’s lead development product, Medidur is used for posterior of the eye (posterior uveitis).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.